<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>International Journal of Radiation Research</title>
<title_fa>نشریه پرتو پژوه</title_fa>
<short_title>Int J Radiat Res</short_title>
<subject>Basic Sciences</subject>
<web_url>http://ijrr.com</web_url>
<journal_hbi_system_id>79</journal_hbi_system_id>
<journal_hbi_system_user>journal79</journal_hbi_system_user>
<journal_id_issn>2322-3243</journal_id_issn>
<journal_id_issn_online>2345-4229</journal_id_issn_online>
<journal_id_pii></journal_id_pii>
<journal_id_doi>10.61882/ijrr</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid></journal_id_sid>
<journal_id_nlai></journal_id_nlai>
<journal_id_science></journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1404</year>
	<month>1</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2025</year>
	<month>4</month>
	<day>1</day>
</pubdate>
<volume>23</volume>
<number>2</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>A practical method of target volume delineation based on peritumoral edema in radiation therapy of glioblastoma</title>
	<subject_fa>Radiation Biology</subject_fa>
	<subject>Radiation Biology</subject>
	<content_type_fa>تحقيق بديع</content_type_fa>
	<content_type>Original Research</content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;div style=&quot;text-align: justify;&quot;&gt;&lt;span style=&quot;font-size:10pt&quot;&gt;&lt;span style=&quot;text-justify:newspaper&quot;&gt;&lt;span style=&quot;text-kashida-space:50%&quot;&gt;&lt;span style=&quot;line-height:119%&quot;&gt;&lt;span style=&quot;font-family:Calibri&quot;&gt;&lt;span style=&quot;color:black&quot;&gt;&lt;span lang=&quot;en-US&quot; style=&quot;font-size:9.0pt&quot;&gt;&lt;span style=&quot;font-family:Calibri&quot;&gt;&lt;span style=&quot;color:#1f497d&quot;&gt;&lt;span style=&quot;font-style:italic&quot;&gt;&lt;span style=&quot;font-weight:bold&quot;&gt;&lt;span style=&quot;language:en-US&quot;&gt;Background&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span lang=&quot;en-US&quot; style=&quot;font-size:9.0pt&quot;&gt;&lt;span style=&quot;font-family:Calibri&quot;&gt;&lt;span style=&quot;color:#1f497d&quot;&gt;&lt;span style=&quot;font-weight:bold&quot;&gt;&lt;span style=&quot;language:en-US&quot;&gt;:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt; &lt;span lang=&quot;en-GB&quot; style=&quot;font-size:9.0pt&quot;&gt;&lt;span style=&quot;font-family:Calibri&quot;&gt;&lt;span style=&quot;color:black&quot;&gt;&lt;span style=&quot;language:en-GB&quot;&gt;To introduce a simple glioblastoma (GBM) target delineation method based on peritumoral edema. &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span lang=&quot;en-GB&quot; style=&quot;font-size:9.0pt&quot;&gt;&lt;span style=&quot;font-family:Calibri&quot;&gt;&lt;span style=&quot;color:#1f497d&quot;&gt;&lt;span style=&quot;font-style:italic&quot;&gt;&lt;span style=&quot;font-weight:bold&quot;&gt;&lt;span style=&quot;language:en-GB&quot;&gt;Materials and Methods: &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span lang=&quot;en-GB&quot; style=&quot;font-size:9.0pt&quot;&gt;&lt;span style=&quot;font-family:Calibri&quot;&gt;&lt;span style=&quot;color:black&quot;&gt;&lt;span style=&quot;language:en-GB&quot;&gt;A postoperative GBM patient was selected, the target volume was delineated using three methods, including the methods recommended by the Radiation Therapy Oncology Group (RTOG method), by the European Organization for Research and Treatment of Cancer (EORTC method) and by this study (New method), and radiotherapy plans were formulated by the same physicist. The dose distributions of each schedule were compared. Then, patients treated with the delineation method recommended in this study were retrospectively analyzed, and progression-free survival and overall survival were determined. &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span lang=&quot;en-GB&quot; style=&quot;font-size:9.0pt&quot;&gt;&lt;span style=&quot;font-family:Calibri&quot;&gt;&lt;span style=&quot;color:#1f497d&quot;&gt;&lt;span style=&quot;font-style:italic&quot;&gt;&lt;span style=&quot;font-weight:bold&quot;&gt;&lt;span style=&quot;language:en-GB&quot;&gt;Results: &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span lang=&quot;en-GB&quot; style=&quot;font-size:9.0pt&quot;&gt;&lt;span style=&quot;font-family:Calibri&quot;&gt;&lt;span style=&quot;color:black&quot;&gt;&lt;span style=&quot;language:en-GB&quot;&gt;The distributions of the high-dose regions of the 3 plans were as follows: RTOG method &gt; EORTC method &gt; New method, as was the low-dose region. Thirty-three patients were included in this retrospective study, and the median progression-free survival (PFS) and overall survival (OS) were 12 and 25 months, respectively. &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span lang=&quot;en-GB&quot; style=&quot;font-size:9.0pt&quot;&gt;&lt;span style=&quot;font-family:Calibri&quot;&gt;&lt;span style=&quot;color:#1f497d&quot;&gt;&lt;span style=&quot;font-style:italic&quot;&gt;&lt;span style=&quot;font-weight:bold&quot;&gt;&lt;span style=&quot;language:en-GB&quot;&gt;Conclusions: &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span lang=&quot;en-GB&quot; style=&quot;font-size:9.0pt&quot;&gt;&lt;span style=&quot;font-family:Calibri&quot;&gt;&lt;span style=&quot;color:black&quot;&gt;&lt;span style=&quot;language:en-GB&quot;&gt;Our study suggested that delineating the target volume for GBM radiotherapy based on peritumoral edema is a good choice.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Glioblastoma, Target volume, Delineating, Peritumoral edema.</keyword>
	<start_page>473</start_page>
	<end_page>480</end_page>
	<web_url>http://ijrr.com/browse.php?a_code=A-10-1-1353&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>H. </first_name>
	<middle_name></middle_name>
	<last_name>Zhang</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>7900319475328460031168</code>
	<orcid>7900319475328460031168</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Radiation Oncology, General Hospital of Northern Theater Command, Shenyang, Liaoning Province, China</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>S. </first_name>
	<middle_name></middle_name>
	<last_name>Hao</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>7900319475328460031169</code>
	<orcid>7900319475328460031169</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Nuclear Medicine, General Hospital of Northern Theater Command, Shenyang, Liaoning Province, China</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>T. </first_name>
	<middle_name></middle_name>
	<last_name>Wu</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>7900319475328460031170</code>
	<orcid>7900319475328460031170</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Radiation Oncology, General Hospital of Northern Theater Command, Shenyang, Liaoning Province, China</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Y. </first_name>
	<middle_name></middle_name>
	<last_name>Xu</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>7900319475328460031171</code>
	<orcid>7900319475328460031171</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Radiation Oncology, General Hospital of Northern Theater Command, Shenyang, Liaoning Province, China</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>D. </first_name>
	<middle_name></middle_name>
	<last_name>Yang</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>7900319475328460031172</code>
	<orcid>7900319475328460031172</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Radiation Oncology, General Hospital of Northern Theater Command, Shenyang, Liaoning Province, China</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Y. </first_name>
	<middle_name></middle_name>
	<last_name>Sun</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>7900319475328460031173</code>
	<orcid>7900319475328460031173</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Radiation Oncology, General Hospital of Northern Theater Command, Shenyang, Liaoning Province, China</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>P. </first_name>
	<middle_name></middle_name>
	<last_name>Zhang</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>7900319475328460031174</code>
	<orcid>7900319475328460031174</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Radiation Oncology, General Hospital of Northern Theater Command, Shenyang, Liaoning Province, China</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Y. </first_name>
	<middle_name></middle_name>
	<last_name>Yan</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>yanyingdoctor@sina.com</email>
	<code>7900319475328460031175</code>
	<orcid>7900319475328460031175</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Department of Radiation Oncology, General Hospital of Northern Theater Command, Shenyang, Liaoning Province, China</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
